This expansion broadens the applicability of gene editing strategies for addressing genomic duplications associated with neurodegenerative diseases like ASD, wherein gene duplications, involving genes such as SHANK3, NRXN1, or NLGN1, have emerged as contributory factors [1–6]. Here, SHANK3 is linked to neurodegenerative disease.